Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 06, 2020 05:30 ET | Source: T-knife GmbH

T-knife Completes €66 Million Series A Financing to Develop Next-Generation T-Cell Therapies

T-knife’s proprietary humanized mouse platform (HuTCR) T-cell receptors expected to provide superior affinity/specificity properties Series A round led by Versant Ventures and RA Capital Management,...